Back to Peptides

Crystagen

Immune Modulation

Crystagen is a thymic-derived peptide bioregulator that modulates immune function, supports thymic repair, and enhances lymphocyte output. It is administered orally and has been shown in Eastern European research to improve immune performance in aging and immunosuppressed individuals.

Administration
Oral
capsules capsule/tablet
Daily Range
1–3 capsules Oral
Daily
Standard Dose
2 capsules
Cycle
4–8 weeks
then reassess
Crystagenimmune peptidethymus bioregulatororal peptidecytogen

Dosing Guide

Administered at 100–200 μg per day in studies. Clinical use is not authorized.

Standard / Gradual Approach

standard
PhaseDose
Week 11000 mcg (1 mg)
Week 21500 mcg (1.5 mg)
Weeks 3–122000 mcg (2 mg)

Protocol Summary

Oral: Daily · Dose range 13 capsules with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending

Frequency & Cycling

Oral

Typical course: 10–30 days of daily dosing. Repeat up to 2–3x per year for immune maintenance.

💊 Quick Start

Starting Dose
1000 mcg (1 mg) (15 units (0.15 mL))
Maintenance Dose
2000 mcg (2 mg) (30 units (0.30 mL))

Potential Benefits & Use Cases

Crystagen is a thymic bioregulatory peptide not approved for clinical use. For research only.
May support immune system modulation through thymic bioregulatory peptide mechanisms (preclinical)
Preserves thymic cortex-medulla division and stimulates thymocyte proliferation in irradiated rats (preclinical)
Normalized immunogram in 82% of elderly patients — increased CD3+ and CD4+ cells, normalized CD4+/CD8+ ratio (limited human data)
Clinical data Strong preclinical Limited data

Mechanism of Action

Normalizes thymus-derived peptide signaling pathways
Stimulates lymphocyte differentiation and cytokine balance
Restores immune regulatory gene expression in aged individuals

Lifestyle & Optimization

timing

Consistent daily dosing.

diet

Balanced nutrient-dense diet. Stay hydrated.

exercise

Regular physical activity.

sleep

Adequate sleep (7–9 hours). Manage stress.

Side Effects & Safety

🧬

Bioavailability & Absorption

SubQ Injection
Not applicable to this compound
Oral Administration
Formulated for oral delivery via capsule; effective for gene modulation at low doses
Half-Life
Not published; effects persist through gene expression regulation
Degradation
Metabolized via standard proteolytic peptide pathways
Tissue Specificity
Thymus, lymph nodes, and peripheral immune cells
⚗️

Peptide Details

Molecular Weight
467.57
Formula
C23H37N5O6
Sequence
Ala-Glu-Asp-Gly
⚖️

Legal Status & Regulatory

RegionStatus
FDANot Approved
EUNot Approved
AustraliaNot Approved
CanadaNot Approved

Storage Instructions

Lyophilized (Powder)
refrigerate at 4 °C (39.2 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 4 °C (39.2 °F) for up to 30 days
Reconstituted (Mixed)
Refrigerate at 4 °C (39.2 °F); stable for approximately 30 days